Business Context and Reporting Period
Company: InspireMD, Inc. (NSPR)
Filing Type: Form 8-K (Current Report)
Date of Report: July 17, 2026
Reporting Period: The filing addresses a specific event occurring on July 17, 2026, regarding the company's listing status on The Nasdaq Capital Market.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on regulatory compliance regarding stock listing standards.
Material Changes
- Listing Non-Compliance: The Company received notice from Nasdaq that it failed to meet the minimum bid price requirement of $1.00 per share under Listing Rule 5550(a)(2).
- Price History: The non-compliance is based on the closing bid price of the common stock for the 30 consecutive business days from June 3, 2026, through July 16, 2026.
- Trading Status: The notice has no immediate effect; the stock continues to trade on The Nasdaq Capital Market under the symbol "NSPR."
Outlook, Risks, and Management Commentary
- Compliance Period: The Company has been granted an initial 180-calendar-day compliance period ending January 13, 2027.
- Remediation Requirements: To regain compliance, the closing bid price must be at least $1.00 per share for a minimum of ten consecutive business days during the compliance period.
- Future Options: If compliance is not met by January 13, 2027, the Company may be eligible for an additional 180-day period if it meets other listing standards (e.g., market value of publicly held shares) and notifies Nasdaq of its intent to cure, potentially via a reverse stock split.
- Risks: There is no assurance the Company will regain compliance or maintain other listing requirements. Failure to cure the deficiency could result in delisting.
- Management Action: The Company intends to actively monitor the stock price and evaluate options, including a reverse stock split, to regain compliance.
Investor Verification Checklist
- Verify the current closing bid price of NSPR to assess proximity to the $1.00 threshold.
- Monitor future announcements regarding the potential execution of a reverse stock split.
- Check for any subsequent Nasdaq notices regarding the extension of the compliance period or delisting determinations.
- Review the Company's market value of publicly held shares to determine eligibility for a second compliance period if the first is unsuccessful.